⸺ Synova Research
Tesamorelin Pre-filled Pen (ChemAesthetic)
ChemAesthetic Tesamorelin (GHRH analogue) supplied as a ready-to-use pre-filled pen — pH balanced, stabilised formula. Sold for research use only.
Secure checkout via UK open banking. Free shipping on orders over £100.
Next-day UK dispatch
Order before midnight
Research use only
Not for human consumption
⸺ Important
- • Strictly for laboratory research
⸺ Overview
About Tesamorelin Pre-filled Pen (ChemAesthetic)
A pre-filled pen presentation of Tesamorelin by ChemAesthetic. Each 3ml cartridge is pH balanced with a stabilised formula and arrives ready for laboratory use — no reconstitution required. Researchers use it in preclinical studies of growth hormone release, lipolysis and metabolic markers.
⸺ Mechanism of Action
How it works
Tesamorelin binds the GHRH receptor on pituitary somatotrophs, increasing pulsatile growth hormone release. The resulting rise in IGF-1 is studied for its influence on lipolysis, protein synthesis and insulin-sensitivity markers in animal models.
⸺ Research
Areas of study
Visceral fat in preclinical models
Animal research describes reductions in visceral adipose tissue markers following sustained Tesamorelin exposure.
Growth hormone axis
Studies report increased pulsatile GH release and downstream IGF-1 elevation in preclinical models.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details
Specification
- CAS
- 218949-48-5
- Intended use
- Research use only. Supplied as a pre-filled pen (3ml cartridge).
- Storage
- Store in a refrigerator (2°C to 8°C). Keep in original carton, away from light.
- Solubility
- Pre-filled pH balanced solution. No reconstitution required.
- Shelf life
- Refer to printed expiry on carton. Once first used, follow manufacturer guidance on in-use stability.
- Handling
- Read the package leaflet before use. Use standard sanitisation technique when handling.
You might also research
View all →
R3TA
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.
T1RZ
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.